跳至主要内容
临床试验/NL-OMON39150
NL-OMON39150已完成4 期

Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days) - FUTIRST (Febrile Urinary Tract Infection Randomized Short Treatment)

eids Universitair Medisch Centrum0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Competent patient aged 18 years or above
  • 2. One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or urgency*; perineal or suprapubic pain; costo-vertebral tenderness or flank pain)
  • 3. Fever (ear or rectal temp of 38.2 oC or higher, or axillary temp of 38 oC or higher), or history of feeling feverish with shivering or rigors in the past 24 hours
  • 4. Positive urine nitrate test and/or leucocyturia as depicted by positive leukocyte esterase test or microscopy

排除标准

  • 1. Known allergy to fluoroquinolones
  • 2. Female patients who are pregnant or lactating
  • 3. Patients with known polycystic kidney disease
  • 4. Patients on permanent renal replacement therapy (hemodialysis or peritoneal dialysis)
  • 5. Patients with history of kidney transplantation
  • 6. Residence outside country of enrolment
  • 7. Inability to speak or read Dutch

研究者

相似试验